Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 81 - 90 of 200 for wx. (0.06 seconds)

China currently ranks number two in the world in the...
WuXi PharmaTech (药明康德), a bellwether for...
PPD, Inc. will acquire BioDuro, a preclinical CRO, as a...
Two of China’s major CROs were named to Deloitte...
Fosun Pharma will raise up to 635 million RMB ($93.4...
Shanghai ChemPartner, a subsidiary of CRO ShangPharma,...
WuXi AppTec and QIAGEN formed a partnership focused on...
The world of China life science is...
Covance, the global CRO, announced construction is...
WuXi PharmaTech (药明康德) reported its Suzhou...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here